Your browser doesn't support javascript.
loading
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
Martínez, Carmen; Díaz-López, Antonio; Rodriguez-Calvillo, Mercedes; García-Sanz, Ramón; Terol, María José; Pérez-Ceballos, Elena; Jiménez, Maria J; Cantalapiedra, Alberto; Domingo-Domenech, Eva; Rodriguez, María José; Sampol, Antonia; Espeso, Manuel; López, Francisco-Javier; Briones, Javier; García, Juan F; Sureda, Anna.
Affiliation
  • Martínez C; Department of Haematology, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Díaz-López A; Pathology Department, MD Anderson Cancer Centre, Madrid, Spain.
  • Rodriguez-Calvillo M; Department of Haematology, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • García-Sanz R; Department of Haematology, Hospital Clínico of Salamanca, Salamanca, Spain.
  • Terol MJ; Department of Haematology, Hospital Clínico of Valencia, Valencia, Spain.
  • Pérez-Ceballos E; Department of Haematology, Hospital Morales Messeguer of Murcia, Murcia, Spain.
  • Jiménez MJ; Department of Haematology, Hospital Germans Trias i Pujol of Barcelona, Barcelona, Spain.
  • Cantalapiedra A; Department of Haematology, Hospital Río Hortega of Valladolid, Valladolid, Spain.
  • Domingo-Domenech E; Department of Haematology, Hospital Duran i Reynals of Barcelona, Barcelona, Spain.
  • Rodriguez MJ; Department of Haematology, Hospital Universitario de Canarias, Tenerife, Spain.
  • Sampol A; Department of Haematology, Hospital Universitari Son Espases of Mallorca, Palma Mallorca, Spain.
  • Espeso M; Department of Haematology, Complejo Hospitalario Carlos Haya of Málaga, Malaga, Spain.
  • López FJ; Department of Haematology, Hospital Ramón y Cajal of Madrid, Madrid, Spain.
  • Briones J; Department of Haematology, Hospital de la Santa Creu i Sant Pau of Barcelona, Barcelona, Spain.
  • García JF; Pathology Department, MD Anderson Cancer Centre, Madrid, Spain.
  • Sureda A; Department of Haematology, Hospital Duran i Reynals of Barcelona, Barcelona, Spain.
Br J Haematol ; 174(6): 859-67, 2016 Sep.
Article de En | MEDLINE | ID: mdl-27185197
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Hodgkin / Protocoles de polychimiothérapie antinéoplasique Type d'étude: Clinical_trials / Diagnostic_studies / Prognostic_studies Langue: En Journal: Br J Haematol Année: 2016 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Hodgkin / Protocoles de polychimiothérapie antinéoplasique Type d'étude: Clinical_trials / Diagnostic_studies / Prognostic_studies Langue: En Journal: Br J Haematol Année: 2016 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Royaume-Uni